The Association Between Systemic Inflammation as Measured by Calprotectin and Autoantibody Load in Rheumatoid Arthritis
Open Access
- 21 October 2026
- journal article
- Published by Wiley in Arthritis & Rheumatology
Abstract
Objective: Plasma calprotectin is a marker of neutrophil activity. Its relation to the clinical phenotype and autoantibodies in rheumatoid arthritis (RA) is only partly understood. We therefore aimed to investigate the association between calprotectin and the clinical parameters C‐reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti–cyclic citrullinated peptide 2 (anti‐CCP2), and other anti–modified protein antibodies (AMPAs) in patients with RA. Methods: Rheumatoid factor (RF), anti‐CCP2 isotypes, and plasma calprotectin were centrally measured in a cross‐sectional cohort of 4,521 Scandinavian patients with RA using fluoro‐enzyme immunoassays. IgG to 15 citrullinated (Cit) and 4 carbamylated or acetylated (Carb/Acet) peptides were measured by multiplex solid‐phase array. CRP and ESR values were obtained from clinical measurements at the time of blood sampling. Results: Calprotectin levels correlated with ESR (ρ = 0.53), CRP (ρ = 0.47), visual analog scale (VAS) pain (ρ = 0.24), Swollen Joint Count in 28 joints (SJC28; ρ = 0.39), and Tender Joint Count in 28 joints (TJC28; ρ = 0.26; P < 0.0001 for all). Patients with both elevated CRP (>10 mg/L) and calprotectin (>15 arbitrary units/mL) (14%, n = 613) had significantly higher VAS pain, SJC28, and TJC28 scores than patients with only elevated CRP ( P < 0.0001), in early and established disease. Patients with elevated calprotectin, independent of CRP levels, had significantly higher proportions of AMPA positivity, including anti‐CCP2. When patients were divided into six groups based on increasing number of Cit/Carb/Acet reactivities and anti‐CCP2 IgG levels, elevated calprotectin was associated with increasing AMPA load, particularly in the presence of RF IgM. The differences between AMPA load groups remained after adjusting for sex, age, RF IgM, and disease duration. Conclusion: Plasma calprotectin is positively associated with seropositivity and AMPA load by autoantibody levels and the breadth of the autoantibody response.Keywords
Funding Information
- Reumatikerförbundet (R‐1012541)
- Reumatikerförbundet (R‐1033940)
- Stiftelsen Konung Gustaf V:s 80-årsfond (FAI‐2023‐0956)
- Stiftelsen Konung Gustaf V:s 80-årsfond (FAI‐2025‐1172)
- NordForsk (90825‐Project_NORA)
- Hjärt-Lungfonden (20250711)
- VINNOVA (2024‐01145)
- Vetenskapsrådet (2023‐01827)
- Vetenskapsrådet (2023‐02497)
This publication has 35 references indexed in Scilit:
- Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid ArthritisArthritis & Rheumatology, 2025
- Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor BaricitinibArthritis & Rheumatology, 2024
- The peculiar features, diversity and impact of citrulline-reactive autoantibodiesNature Reviews Rheumatology, 2024
- Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic StudyRheumatology and Therapy, 2024
- A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients With Rheumatoid ArthritisArthritis & Rheumatology, 2019
- Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis PatientsArthritis Care & Research, 2018
- The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targetingNature Reviews Immunology, 2016
- Serum Calprotectin Versus Acute‐Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor InhibitorsArthritis Care & Research, 2016
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells.Journal of Biological Chemistry, 1991